AM404结构式
|
常用名 | AM404 | 英文名 | AM404 |
---|---|---|---|---|
CAS号 | 183718-77-6 | 分子量 | 395.578 | |
密度 | 1.0±0.1 g/cm3 | 沸点 | 579.4±50.0 °C at 760 mmHg | |
分子式 | C26H37NO2 | 熔点 | N/A | |
MSDS | 美版 | 闪点 | 304.2±30.1 °C | |
符号 |
GHS02, GHS07 |
信号词 | Danger |
AM404用途AM404是一种内源性大麻素再摄取抑制剂,在低微摩尔范围内阻断阿难酰胺的IC50值运输[1]。AM404能够松弛用苯肾上腺素收缩的大鼠离体肝动脉,pEC50值为7.4(对应于0.04µM的EC50)。神经保护作用[2]。 |
英文名 | N-(4-hydroxyphenyl)icosa-5,8,11,14-tetraenamide |
---|---|
英文别名 | 更多 |
描述 | AM404是一种内源性大麻素再摄取抑制剂,在低微摩尔范围内阻断阿难酰胺的IC50值运输[1]。AM404能够松弛用苯肾上腺素收缩的大鼠离体肝动脉,pEC50值为7.4(对应于0.04µM的EC50)。神经保护作用[2]。 |
---|---|
相关类别 | |
体外研究 | AM404的IC50值为4.9µM,可减少C6胶质瘤细胞增殖。AM404在用于阻止内源性大麻素anandamide的细胞聚集的浓度下,非特异性地抑制C6胶质瘤细胞增殖[2]。细胞活性测定[2]细胞系:大鼠C6胶质瘤细胞浓度:1,3,10和30µM培养时间:24,48,72和96 h结果:在暴露于10和30µM浓度的24 h和暴露于3µM浓度的48 h后,细胞增殖产生浓度依赖性降低,在72小时时,细胞增殖显著减少,尽管很小。 |
体内研究 | AM404(1-5) mg/kg,i.p.)在三种模型中发挥剂量依赖性抗焦虑作用:高架+迷宫、防御性戒断和分离诱导的超声波发声。动物模型:成年雄性Sprague-Dawley大鼠(250-300只) g) [2]剂量:2.5-10 mg/kg给药:腹腔注射(i.p.)结果:导致前额叶皮质、海马和丘脑中的阿南达胺水平呈剂量依赖性增加。 |
参考文献 |
密度 | 1.0±0.1 g/cm3 |
---|---|
沸点 | 579.4±50.0 °C at 760 mmHg |
分子式 | C26H37NO2 |
分子量 | 395.578 |
闪点 | 304.2±30.1 °C |
精确质量 | 395.282440 |
PSA | 49.33000 |
LogP | 7.63 |
蒸汽压 | 0.0±1.7 mmHg at 25°C |
折射率 | 1.555 |
储存条件 | -20°C,密闭,干燥 |
符号 |
GHS02, GHS07 |
---|---|
信号词 | Danger |
危害声明 | H225-H319 |
警示性声明 | P210-P280-P305 + P351 + P338-P337 + P313-P403 + P235 |
个人防护装备 | Eyeshields;Faceshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter |
危害码 (欧洲) | F: Flammable; |
风险声明 (欧洲) | R36/37/38 |
安全声明 (欧洲) | S7 |
危险品运输编码 | UN 1170 3/PG 2 |
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia.
Transl. Psychiatry 2 , e94, (2012) Cannabidiol is a component of marijuana that does not activate cannabinoid receptors, but moderately inhibits the degradation of the endocannabinoid anandamide. We previously reported that an elevatio... |
|
The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats.
Br. J. Pharmacol. 165(8) , 2539-48, (2012) The fatty acid amide hydrolase inhibitor URB597 can reverse the abuse-related behavioural and neurochemical effects of nicotine in rats. Fatty acid amide hydrolase inhibitors block the degradation (an... |
|
Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404.
Eur. J. Pharmacol. 408(2) , 161-8, (2000) The biological actions of the endogenous cannabinoid anandamide are terminated by carrier-mediated transport into neurons and astrocytes, followed by enzymatic hydrolysis. Anandamide transport is inhi... |
N-(4-Hydroxyphenyl)-arachidonylamide |
5,8,11,14-Eicosatetraenamide, N-(4-hydroxyphenyl)-, (5Z,8Z,11Z,14Z)- |
AM 404 |
(5Z,8Z,11Z,14Z)-N-(4-Hydroxyphenyl)icosa-5,8,11,14-tetraenamide |
N-(4-Hydroxyphenyl)arachidonylamide |
AM-404 |
AM404 |
(5Z,8Z,11Z,14Z)-N-(4-Hydroxyphenyl)-5,8,11,14-icosatetraenamide |